Moreover, digoxin and digitoxin, two other cardiac glycosides usually used in cardiac diseases, decrease IMR90 survival by apoptosis in OIS
To date, prescribed GLP-1s have been characterized by sky-high costs, especially as they have been affected by supply issues due to an increase in demand
The quest for selective nox inhibitors and therapeutics: challenges, triumphs and pitfalls
Oral bioavailability of MEDI7219 tablets Oral tablet formulation Tablets contained 0.510 mg of MEDI7219, 150 mg of permeation enhancers (50 mg NaCDC [Prodotti, Basaluzzo, Italy] and 100 mg PG [Guangzhou Hanfang Pharmaceutical, Guangzhou, China]), mannitol (Roquette, Keokuk, IA, USA) as filler, crospovidone (BASF, Ludwigshafen, Germany) as disintegrant, sodium stearyl fumarate (JRS Pharma, Rosenberg, Germany) as lubricant and hydrophobic fumed silica (Evonik, Parsippany, NJ, USA) as glidant, with a total weight of 245 mg per tablet